1. Home
  2. VOR vs UFCS Comparison

VOR vs UFCS Comparison

Compare VOR & UFCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$22.53

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo United Fire Group Inc.

UFCS

United Fire Group Inc.

HOLD

Current Price

$53.87

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VOR
UFCS
Founded
2015
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
VOR
UFCS
Price
$22.53
$53.87
Analyst Decision
Buy
Buy
Analyst Count
10
2
Target Price
$45.33
$40.50
AVG Volume (30 Days)
754.9K
112.5K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
2.01%
EPS Growth
N/A
87.45
EPS
N/A
2.45
Revenue
N/A
$1,386,412,000.00
Revenue This Year
N/A
$11.80
Revenue Next Year
N/A
$8.77
P/E Ratio
N/A
$21.99
Revenue Growth
N/A
10.62
52 Week Low
$1.90
$29.75
52 Week High
$49.95
$55.82

Technical Indicators

Market Signals
Indicator
VOR
UFCS
Relative Strength Index (RSI) 55.02 58.42
Support Level $21.75 $52.01
Resistance Level $24.44 $55.82
Average True Range (ATR) 1.05 1.34
MACD -0.19 -0.05
Stochastic Oscillator 41.40 75.24

Price Performance

Historical Comparison
VOR
UFCS

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

About UFCS United Fire Group Inc.

United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.

Share on Social Networks: